Our results confirmed that SERPINB5 decreased the overall survival of the CRC patients, but the prognostic analysis using datasets from TCGA showed no prognostic significance of SERPINB5 in CRC patients. This evidence concerns the gene SERPINB5 and colorectal carcinoma.